Doubling Down Following up on our recent white paper, Biopharma’s COVID Capital Comeback, here is a look at the greatest risk […]
Q3 2020 Report: Global Trends in Biopharma Transactions Each quarter our team at Locust Walk compiles key statistics and trends on strategic
Biopharma’s COVID Capital Comeback What a difference a few months can make – especially during a pandemic. Heading into 2020,
Brave New World: Challenges from the East, Asia Biopharma, and Response to COVID-19 SUBSCRIBE TO OUR INSIGHTS Linkedin Twitter Youtube
A Brave New World COVID-19 or SARS Cov-2 to be precise, has changed the world in many regards. From the
Panel Recording on 6.11: Accessing Capital in the Time of COVID CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Panel Recording on 5.7: Biopharma Deal Maker’s Guide to Strategic Partnerships CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Panel Recording on 4.16: Q1 2020 Biopharma Market Conditions Live Panel CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Q1 2020 Biopharma Report Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and
Q1 2020 Biopharma Report Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and